Condition: Anal Canal Cancer
Intervention: Radiation: chemo-radiation treatment
Sponsor: AHS Cancer Control Alberta
Not yet recruiting
Feeds
6810 items (6810 unread) in 74 feeds
Acinar Cell Carcinoma
(81 unread)
Acinic Cell Carcinoma
(46 unread)
Adenoid Cystic Carcinoma
(159 unread)
Adrenal Gland Cancer
(533 unread)
Ampulla Of Vater
(68 unread)
Anal Cancer
(425 unread)
Angiosarcoma
(153 unread)
Appendix Cancer
(104 unread)
Bile Duct Cancer
(845 unread)
Brain and CNS
(878 unread)
Carcinoid
(266 unread)
Endocrine/Neuroendocrine
(808 unread)
Gall Bladder Cancer
(381 unread)
Hemangioendothelioma
(215 unread)
Hepatoblastoma
(129 unread)
Pancreas
(117 unread)
Phyllodes
(105 unread)
PMP and Mucinous Tumors
(114 unread)
Rhabdomyosarcoma
(246 unread)
Sarcoma
(1137 unread)
Trial - Anal Cancers (9 unread)
-
Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer
Posted: September 10th, 2021, 2:00pm GMT
-
Study of the Association Between Tumor Microenvironment Macrophages and Treatment Response in Squamous Cell Carcinoma of the Anal Canal
Posted: August 24th, 2021, 2:00pm GMT
Condition: Squamous Cell Carcinoma
Intervention:
Sponsor: Groupe Hospitalier Paris Saint Joseph
Recruiting -
Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
Posted: May 19th, 2021, 2:00pm GMT
Condition: Adult Solid Tumor
Interventions: Biological: SQZ-AAC-HPV; Drug: Ipilimumab; Drug: Nivolumab
Sponsor: SQZ Biotechnologies
Recruiting -
The Effectiveness of High Resolution Microendoscopy for People Living With HIV
Posted: September 24th, 2020, 2:00pm GMT
Condition: Anal High Grade Squamous Intraepithelial Lesion
Intervention: Diagnostic Test: mHRME (Mobile High resolution microendoscope)
Sponsors: Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; William Marsh Rice University; University of California, San Francisco; The University of Texas Health Science Center, Houston; M.D. Anderson Cancer Center
Recruiting -
EA2176: Phase 3 Clinical Trial of Carboplatin and Pacliitaxel +/- Nivolumab in Metastatic Anal Cancer Patients
Posted: June 24th, 2020, 2:00pm GMT
Conditions: Anal Basaloid Carcinoma; Anal Canal Cloacogenic Carcinoma; Metastatic Anal Squamous Cell Carcinoma; Recurrent Anal Squamous Cell Carcinoma; Stage III Anal Cancer AJCC v8; Stage IIIA Anal Cancer AJCC v8; Stage IIIB Anal Cancer AJCC v8; Stage IIIC Anal Cancer AJCC v8; Stage IV Anal Cancer AJCC v8; Unresectable Anal Squamous Cell Carcinoma
Interventions: Drug: Carboplatin; Biological: Nivolumab; Drug: Paclitaxel
Sponsor: National Cancer Institute (NCI)
Recruiting -
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
Posted: June 16th, 2020, 2:00pm GMT
Conditions: HPV Positive Cancer; Vulvar, Vaginal, Penile, Rectal Cancer; Anal Cancer; Oropharyngeal Cancer; Cervical Cancer
Interventions: Biological: PRGN-2009; Biological: M7824
Sponsor: National Cancer Institute (NCI)
Recruiting -
Function Following Laser for Anal Intraepithelial Neoplasia (FLAN)
Posted: September 30th, 2019, 2:00pm GMT
Conditions: Anus Cancer; Fecal Incontinence; Anal Intraepithelial Neoplasia; Post Operative Pain
Intervention: Procedure: high resolution anal manometry
Sponsors: Homerton University Hospital NHS Foundation Trust; Barts & The London NHS Trust
Recruiting -
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Posted: August 8th, 2016, 2:00pm GMT
Conditions: Papillomavirus Infections; Cervical Intraepithelial Neoplasia; Carcinoma In Situ; Vulvar Neoplasms; Vulvar Diseases
Interventions: Biological: E7 TCR cells; Drug: Aldesleukin; Drug: Fludarabine; Drug: Cyclophosphamide
Sponsor: National Cancer Institute (NCI)
Recruiting -
Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions
Posted: February 11th, 2014, 3:00pm GMT
Conditions: Anal Intraepithelial Neoplasia; High-grade Squamous Intraepithelial Lesion; HIV Infection
Interventions: Drug: imiquimod; Drug: fluorouracil; Other: questionnaire administration; Other: laboratory biomarker analysis
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI); The Emmes Company, LLC; University of Arkansas
Recruiting